%20to%20Reduce%20Cardiovascular%20Mortality%2C%20Cardiovascular%20Hospitalizations%20and%20Urgent%20Heart%20Failure%20Visits%20(dragged)-1759607143350.webp&w=3840&q=75)
2025 SPS Seattle | Vutrisiran in the Wild-Type or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy
0% Complete
Course Content
Credits
- AMA PRA Category 1 Credit™Non-CME
Course Details
- Duration
- 0.00 hour
- Released
- Oct 5, 2025
- Last Review
- Oct 5, 2025
- Expires
- Oct 5, 2026
Target Audience
Pharmacists
Faculty & Disclosure
Faculty
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE
Accreditation
NA
Related Courses
2026 SPS Twin Cities | Hyaluronidase Delivering New Subcutaneous Dosage Forms Throughout Various Therapeutic Areas: A Dive into Clinical, Safety, Practice and Economic Considerations
0.00 Credits
1 Chapter
Pharmacology
Free
2026 SPS Twin Cities | CMS Drug Price Negotiations Through Maximum Fair Price (MFP): Access & Practice Considerations Now & Then
0.00 Credits
1 Chapter
Pharmacology
Free